Evidence map›Paper›PMID 19118303›Full record

ArticleThe New England journal of medicine2009

A syndrome with congenital neutropenia and mutations in G6PC3.

Kaan Boztug, Giridharan Appaswamy, Angel Ashikov, Alejandro A Schäffer, Ulrich Salzer, Jana Diestelhorst, Manuela Germeshausen, Gudrun Brandes, Jacqueline Lee-Gossler, Fatih Noyan and 16 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The New England journal of medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05078879 (A Phase 1 Study of Empagliflozin as Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency), which is not on this map. Cited by 158 papers.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05078879 phase1completednot on this mapstarted 2021, after this paper: background citation

A Phase 1 Study of Empagliflozin as Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2021 to 2025Enrolled4ConditionsCrohn's Disease, Glycogen Metabolism, Inflammatory Bowel Disease (IBD)ArmsEmpagliflozin
3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 348 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Structural basis of G6P/Pi transport and inhibition in SLC37A4.Nature structural & molecular biology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The metabolic basis of inherited neutropenias.British journal of haematology · 2024
    Review
  20. Human Genetics of Atrial Septal Defect.Advances in experimental medicine and biology · 2024
    Review

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 8 countries.

Kaan BoztugHannover Medical School, Hannover, Germany.
Giridharan Appaswamy
Angel Ashikov
Alejandro A Schäffer
Ulrich Salzer
Jana Diestelhorst
Manuela Germeshausen
Gudrun Brandes
Jacqueline Lee-Gossler
Fatih Noyan
Anna-Katherina Gatzke
Milen Minkov
Johann Greil
Christian Kratz
Theoni Petropoulou
Isabelle Pellier
Christine Bellanné-Chantelot
Nima Rezaei
Kirsten Mönkemöller
Noha Irani-Hakimeh
Hans Bakker
Rita Gerardy-Schahn
Cornelia Zeidler
Bodo Grimbacher
Karl Welte
Christoph Klein
Medizinische Hochschule Hannover · DEAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire d'Angers · FRChildren's Hospital Agia Sophia · GRHeidelberg University · DENational Center for Biotechnology Information · USSaint George Hospital · LBSt Anna Children's Hospital · ATTehran University of Medical Sciences · IRThe Royal Free Hospital · GBUniversity Medical Center Freiburg · DEUniversity of Freiburg · DE

Funding

Case Studies In GeneticsZIALM000097 · NLM · NATIONAL LIBRARY OF MEDICINE · PI SCHAFFER, ALEJANDRO A · 2009 to 2019
$4.6M
Case Studies In GeneticsZ01LM000097 · NLM · NATIONAL LIBRARY OF MEDICINE · PI SCHAFFER, ALEJANDRO A · 2002 to 2008
$452k
Intramural NIH HHS Z01 LM000097Intramural NIH HHS Z99 LM999999
6 · The paper itself

Abstract

backgroundThe main features of severe congenital neutropenia are the onset of severe bacterial infections early in life, a paucity of mature neutrophils, and an increased risk of leukemia. In many patients, the genetic causes of severe congenital neutropenia are unknown.

methodsWe performed genomewide genotyping and linkage analysis on two consanguineous pedigrees with a total of five children affected with severe congenital neutropenia. Candidate genes from the linkage interval were sequenced. Functional assays and reconstitution experiments were carried out.

resultsAll index patients were susceptible to bacterial infections and had very few mature neutrophils in the bone marrow; structural heart defects, urogenital abnormalities, and venous angiectasia on the trunk and extremities were additional features. Linkage analysis of the two index families yielded a combined multipoint lod score of 5.74 on a linkage interval on chromosome 17q21. Sequencing of G6PC3, the candidate gene encoding glucose-6-phosphatase, catalytic subunit 3, revealed a homozygous missense mutation in exon 6 that abolished the enzymatic activity of glucose-6-phosphatase in all affected children in the two families. The patients' neutrophils and fibroblasts had increased susceptibility to apoptosis. The myeloid cells showed evidence of increased endoplasmic reticulum stress and increased activity of glycogen synthase kinase 3beta (GSK-3beta). We identified seven additional, unrelated patients who had severe congenital neutropenia with syndromic features and distinct biallelic mutations in G6PC3.

conclusionsDefective function of glucose-6-phosphatase, catalytic subunit 3, underlies a severe congenital neutropenia syndrome associated with cardiac and urogenital malformations.

Indexed as

Mutation, MissenseAbnormalities, MultipleAdolescentApoptosisChildChild, PreschoolDNA Mutational AnalysisFemaleGenome-Wide Association StudyGlucose-6-PhosphataseGlycogen Storage Disease Type IHeart Defects, CongenitalHumansInfantLod ScoreMaleGlucose-6-Phosphatase

Identifiers

PMID19118303
PMCPMC2778311
OpenAlexW2039811582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.